KF
CRL icon

Kresge Foundation’s Charles River Laboratories CRL Stock Holding History

Kresge Foundation’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-16,000
Closed -$1.8M – 7
2018
Q4 		$1.8M Buy
+16,000
New +$2M 3.68% 9

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Kresge Foundation's CRL Position: Q1 2019 in Review

Kresge Foundation sold out of Charles River Laboratories (CRL) in Q1 2019, closing a stake of 16,000 shares — an estimated $1.8M sold.

Kresge Foundation first reported a position in CRL in Q4 2018 and held it in 1 quarter. The position peaked at $1.8M in Q4 2018. 409 funds tracked by Wall St. Rank hold CRL as of Q1 2019.

  • Kresge Foundation reported no remaining Charles River Laboratories position as of Q1 2019 after selling out during the quarter.
  • Kresge Foundation sold 16,000 Charles River Laboratories shares in Q1 2019, an estimated $1.8M.
  • Kresge Foundation first reported a position in Charles River Laboratories in Q4 2018 and held it in 1 quarter.
  • Kresge Foundation's Charles River Laboratories position peaked at $1.8M in Q4 2018.
  • 409 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2019.

Based on Kresge Foundation's 13F filing for Q1 2019.